Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
GnRH agonist
DRUG CLASS:
GnRH agonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprolide 6-month depot (1)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
leuprolide acetate (14)
triptorelin (9)
goserelin acetate (7)
histrelin acetate (5)
leuprolide 6-month depot (1)
leuprorelin depot (1)
leuprolide acetate for depot suspension (1)
buserelin acetate (0)
›
Associations
(39)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
histrelin acetate
Sensitive: A1 - Approval
histrelin acetate
Sensitive
:
A1
histrelin acetate
Sensitive: A1 - Approval
histrelin acetate
Sensitive
:
A1
No biomarker
Breast Cancer
No biomarker
Breast Cancer
leuprolide acetate for depot suspension
Sensitive: A1 - Approval
leuprolide acetate for depot suspension
Sensitive
:
A1
leuprolide acetate for depot suspension
Sensitive: A1 - Approval
leuprolide acetate for depot suspension
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
goserelin acetate + flutamide
Sensitive: A1 - Approval
goserelin acetate + flutamide
Sensitive
:
A1
goserelin acetate + flutamide
Sensitive: A1 - Approval
goserelin acetate + flutamide
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
goserelin acetate
Sensitive: A1 - Approval
goserelin acetate
Sensitive
:
A1
goserelin acetate
Sensitive: A1 - Approval
goserelin acetate
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide 6-month depot
Sensitive: A1 - Approval
leuprolide 6-month depot
Sensitive
:
A1
leuprolide 6-month depot
Sensitive: A1 - Approval
leuprolide 6-month depot
Sensitive
:
A1
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprorelin depot
Sensitive: A1 - Approval
leuprorelin depot
Sensitive
:
A1
leuprorelin depot
Sensitive: A1 - Approval
leuprorelin depot
Sensitive
:
A1
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
goserelin acetate
Sensitive: A1 - Approval
goserelin acetate
Sensitive
:
A1
goserelin acetate
Sensitive: A1 - Approval
goserelin acetate
Sensitive
:
A1
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
AR positive
Salivary Gland Cancer
AR positive
Salivary Gland Cancer
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
histrelin acetate + nilutamide
Sensitive: A2 - Guideline
histrelin acetate + nilutamide
Sensitive
:
A2
histrelin acetate + nilutamide
Sensitive: A2 - Guideline
histrelin acetate + nilutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
bicalutamide + goserelin acetate
Sensitive: A2 - Guideline
bicalutamide + goserelin acetate
Sensitive
:
A2
bicalutamide + goserelin acetate
Sensitive: A2 - Guideline
bicalutamide + goserelin acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
goserelin acetate + nilutamide
Sensitive: A2 - Guideline
goserelin acetate + nilutamide
Sensitive
:
A2
goserelin acetate + nilutamide
Sensitive: A2 - Guideline
goserelin acetate + nilutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
triptorelin
Sensitive: A2 - Guideline
triptorelin
Sensitive
:
A2
triptorelin
Sensitive: A2 - Guideline
triptorelin
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
leuprolide acetate
Sensitive: A2 - Guideline
leuprolide acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
abiraterone acetate + triptorelin
Sensitive: A2 - Guideline
abiraterone acetate + triptorelin
Sensitive
:
A2
abiraterone acetate + triptorelin
Sensitive: A2 - Guideline
abiraterone acetate + triptorelin
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
abiraterone acetate + leuprolide acetate
Sensitive: A2 - Guideline
abiraterone acetate + leuprolide acetate
Sensitive
:
A2
abiraterone acetate + leuprolide acetate
Sensitive: A2 - Guideline
abiraterone acetate + leuprolide acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
abiraterone acetate + histrelin acetate
Sensitive: A2 - Guideline
abiraterone acetate + histrelin acetate
Sensitive
:
A2
abiraterone acetate + histrelin acetate
Sensitive: A2 - Guideline
abiraterone acetate + histrelin acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
abiraterone acetate + goserelin acetate
Sensitive: A2 - Guideline
abiraterone acetate + goserelin acetate
Sensitive
:
A2
abiraterone acetate + goserelin acetate
Sensitive: A2 - Guideline
abiraterone acetate + goserelin acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
bicalutamide + triptorelin
Sensitive: A2 - Guideline
bicalutamide + triptorelin
Sensitive
:
A2
bicalutamide + triptorelin
Sensitive: A2 - Guideline
bicalutamide + triptorelin
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
triptorelin + flutamide
Sensitive: A2 - Guideline
triptorelin + flutamide
Sensitive
:
A2
triptorelin + flutamide
Sensitive: A2 - Guideline
triptorelin + flutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
triptorelin + nilutamide
Sensitive: A2 - Guideline
triptorelin + nilutamide
Sensitive
:
A2
triptorelin + nilutamide
Sensitive: A2 - Guideline
triptorelin + nilutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide acetate + bicalutamide
Sensitive: A2 - Guideline
leuprolide acetate + bicalutamide
Sensitive
:
A2
leuprolide acetate + bicalutamide
Sensitive: A2 - Guideline
leuprolide acetate + bicalutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide acetate + flutamide
Sensitive: A2 - Guideline
leuprolide acetate + flutamide
Sensitive
:
A2
leuprolide acetate + flutamide
Sensitive: A2 - Guideline
leuprolide acetate + flutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
leuprolide acetate + nilutamide
Sensitive: A2 - Guideline
leuprolide acetate + nilutamide
Sensitive
:
A2
leuprolide acetate + nilutamide
Sensitive: A2 - Guideline
leuprolide acetate + nilutamide
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
bicalutamide + histrelin acetate
Sensitive: A2 - Guideline
bicalutamide + histrelin acetate
Sensitive
:
A2
bicalutamide + histrelin acetate
Sensitive: A2 - Guideline
bicalutamide + histrelin acetate
Sensitive
:
A2
No biomarker
Prostate Cancer
No biomarker
Prostate Cancer
histrelin acetate + flutamide
Sensitive: A2 - Guideline
histrelin acetate + flutamide
Sensitive
:
A2
histrelin acetate + flutamide
Sensitive: A2 - Guideline
histrelin acetate + flutamide
Sensitive
:
A2
HR positive
Soft Tissue Sarcoma
HR positive
Soft Tissue Sarcoma
GnRH agonist
Sensitive: A2 - Guideline
GnRH agonist
Sensitive
:
A2
GnRH agonist
Sensitive: A2 - Guideline
GnRH agonist
Sensitive
:
A2
ER positive
Estrogen Receptor Positive Breast Cancer
ER positive
Estrogen Receptor Positive Breast Cancer
tamoxifen + goserelin acetate
Sensitive: C2 – Inclusion Criteria
tamoxifen + goserelin acetate
Sensitive
:
C2
tamoxifen + goserelin acetate
Sensitive: C2 – Inclusion Criteria
tamoxifen + goserelin acetate
Sensitive
:
C2
AR positive
Salivary Gland Cancer
AR positive
Salivary Gland Cancer
leuprolide acetate + bicalutamide
Sensitive: C3 – Early Trials
leuprolide acetate + bicalutamide
Sensitive
:
C3
leuprolide acetate + bicalutamide
Sensitive: C3 – Early Trials
leuprolide acetate + bicalutamide
Sensitive
:
C3
PLIN2 expression
Salivary Gland Cancer
PLIN2 expression
Salivary Gland Cancer
leuprolide acetate + bicalutamide
Sensitive: C3 – Early Trials
leuprolide acetate + bicalutamide
Sensitive
:
C3
leuprolide acetate + bicalutamide
Sensitive: C3 – Early Trials
leuprolide acetate + bicalutamide
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login